• About us
        • About ACTA
        • Our vision and mission
        • Why ACTA formed
        • Our members
        • Our Board
        • Our team
        • Our annual reports
        • Our policies
  • Our work
        • All activities
        • Advocacy
        • Australian Teletrial Program (ATP) Project
        • Adaptive Platform Trial Operations Special Interest Group (APTO SIG)
        • Clinical Quality Registries Special Interest Group (CQR SIG)
        • Coordinating Centres Special Interest Group (CC SIG)
        • Health Economics Alongside Trials Special Interest Group (HEAT SIG)
        • Raising Equity of Access to Clinical Trials Special Interest Group (REACT-SIG)
        • Special Interest Group for Clinical Trial Network Managers (SIGNet)
        • Statistics in Trials Special Interest Group (STInG)
        • Translation of Research into Practice Special Interest Group (TRIP SIG)
  • News
  • Resources
        • View our full resource library
        • ACTA resources
        • Sector resources
        • Consumer Involvement and Engagement Toolkit
        • DSMB directory (STInG members only)
        • Find a health economist
        • Find a statistician (STInG members only)
        • Teletrials web resource
  • Events
  • Get involved
        • About ACTA membership
        • Our members
  • Contact Us
  1. Home
  2. COVID-19
  3. Page 2

Topics: COVID-19

News

  • Australian Clinical Trials Alliance celebrating and honouring clinical trials on International Clinical Trials Day

    20.05.2020 This news is coming from ACTA Topics:Advocacy ACTA Members COVID-19
  • ACTA STInG: signatories to open letters addressing statistical analysis and data integrity in COVID-19 publications

    24.06.2020 This news is coming from ACTA Topics:Statistics COVID-19 Advocacy
  • Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia

    03.07.2020 This news is coming from ACTA Topics:Advocacy COVID-19
  • Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency: Guidance for Industry

    03.07.2020 This news is coming from Sector Topics:COVID-19
  • MRFF Grant Opportunity

    03.07.2020 This news is coming from Sector Topics:COVID-19
  • Symposium: Social and ethical implications of the COVID-19 pandemic

    28.08.2020 This news is coming from Sector Topics:COVID-19
  • Vaccines alone won’t keep Australia COVID-safe, review finds

    16.12.2020 This news is coming from Sector Topics:COVID-19
Previous<< 1 2

Quick links

  • About ACTA
  • Activities
  • Events
  • Resources library

Membership

Open to clinical trials networks, clinical trial coordinating centres and clinical quality registries that support ACTA’s mission and vision and meet the membership criteria outlined.

Login Learn More

Newsletter

Be the first to know all ACTA events and featured news through our Newsletter.

You don’t need to be a member to subscribe!

Contact us

0438 801 011

Suite 1, L2 / 24 Albert Road
Melbourne VIC 3205 Australia

Social Media

  • Twitter
  • LinkedIn

Copyright © 2025 Australian Clinical Trials Alliance | ABN: 60 168 693 972 | Privacy Statement | Sitemap

Managed by Cultivate Digital

Login

Lost Password?Become a member